Biotech China 2014
6th European Congress on Hematologic Malignancies from Clinical Science to Clinical Practice
InterContinental Carlton Cannes
58 Boulevard de la Croisette
Cannes, France
http://www.imedex.com/appweb/announcements/a138-01.asp
6th European Congress on Hematologic Malignancies from Clinical Science to Clinical Practice

Schedule of Presentations:

Friday, February 26, 2010
06:00:00 check in
13:00:00 Welcome and introduction
13:00:00 Session I: Myeloma Bertrand Coiffier, Jesus F. San Miguel
13:05:00 Overview of newly diagnosed patients
13:20:00 DEBATE: First-line treatment in the transplant eligible patient Antonio Palumbo, Jean-Luc Harousseau
13:50:00 Current and emerging options for relapsed myeloma Jesus F. San Miguel
14:10:00 DEBATE: Best salvage therapy for the relapsed patient Jesus F. San Miguel, Meletios A. Dimopoulos
14:40:00 The role of VTE prophylaxis in myeloma Antonio Palumbo
15:00:00 Summary of the IMW consensus on response criteria and relevant outcomes Joan Bladé
15:15:00 Chair take-home points for the clinician
15:20:00 Break
15:30:00 Session II: Chronic Lymphocytic Leukemia Eva Kimby
15:40:00 Role of the microenvironment in CLL
16:00:00 Monoclonal B-cell lymphocytosis and CLL Paolo Ghia
16:20:00 Case discussion: Optimal management of the low risk patient
16:50:00 Case discussion: Optimal therapy for the high risk patient
17:20:00 DEBATE: Management of the double-refractory patient
17:50:00 Panel discussion
18:00:00 Chair take-home points for the clinician and adjourn
Saturday, February 27, 2010
08:00:00 Session III: Follicular Lymphoma Eva Kimby, Gilles Salles
09:00:00 Role of the microenvironment in CLL
09:20:00 Overview of maintenance therapy Gilles Salles
09:40:00 DEBATE: Is follicular lymphoma curable? Christian Buske, Michele Ghielmini
10:10:00 DEBATE: The role of stem cell transplant in patients with relapsed follicular lymphoma Rien H.J. van Oers, Bertrand Coiffier
10:40:00 Panel discussion and chair take-home points for the clinician
10:50:00 Break
11:00:00 Session IV: Mantle Cell Lymphoma Eva Kimby
11:10:00 Biology of mantle cell lymphoma Andreas Rosenward
11:30:00 Case discussion: Mantle cell lymphoma therapy in young and old patients
11:50:00 Maintenance therapy after first-line and second-line therapy in MCL Michele Ghielmini
12:10:00 DEBATE: Autologous versus allogeneic transplantation in mantle cell lymphoma Norbert Schmitz
12:40:00 Panel discussion and chair take-home points for the clinician
13:00:00 Lunch
13:05:00 Session V: Aggressive B-cell Non-Hodgkin Lymphoma Michael Pfreundschuh, Bertrand Coiffier
14:30:00 Biology and treatment of bulky and mediastinal large B-cell lymphoma
14:50:00 DEBATE: Prevention and treatment of central nervous system disease Michael Pfreundschuh
15:20:00 DEBATE: Improving high-risk DLBCL in both the young and the elderly Bertrand Coiffier, Michael Pfreundschuh
15:50:00 PROPOSITION: Same treatment for germinal centre (GC) and non-GC patients?
16:10:00 Panel discussion and chair take-home points for the clinician
16:20:00 Break
16:25:00 Session VI: T-Cell Lymphoma Bertrand Coiffier
16:40:00 Pathology overview of T-cell lymphoma Andreas Rosenward
17:00:00 Case discussion: Treatment of nasal type lymphoma (localized and disseminated)
17:20:00 DEBATE: Transplantation in young patients Nicolas Mounier
17:50:00 Panel discussion and chair take-home points for the clinician
18:00:00 Adjourn
Sunday, February 28, 2010
09:00:00 Overview: Improving efficacy and reducing toxicity of localized HD Andreas Engert
09:20:00 Radiation in Hodgkin’s disease Lena Specht
09:40:00 Treatment of relapsing patients Christophe Fermé
10:00:00 Allogeneic transplantation Norbert Schmitz
10:20:00 Panel discussion and chair take-home points for the clinician
10:30:00 Break
10:35:00 Session VIII: SPECIAL SESSION –Acute Lymphoblastic Leukemia Dieter Hoelzer
11:00:00 Recent diagnostic approaches and molecular genetics in acute lymphoblastic leukemia (ALL)
11:25:00 New treatment options in adult ALL including targeted therapy Dieter Hoelzer
11:50:00 Update on achievements in childhood ALL
12:15:00 Minimal residual disease: The most prognostic parameters to stratify and treat ALL Nicola Gökbuget
12:40:00 Panel discussion and chair take-home points for the clinician
13:00:00 Adjourn
15:00:00 End of the conference
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.